Filters
Use basic filters below or open advanced options for more precise results.
Last dataset refresh: 06 Apr 2026
| Product name | Classification | Strength | Form | Manufacturer | Country of origin | Status | Registered On | Action | |
|---|---|---|---|---|---|---|---|---|---|
|
Restylane® Lidocaine
|
Medical Devices for Humans | Combination | Injection | Q-Med AB, Sweden, Seminariegatan 21, Uppsala | Sweden | Active | 07 Oct 2024 | View details → | |
|
Restylane® LYFT LIDOCAINE
|
Medical Devices for Humans | 20mg/ml | Injection | Q-Med AB, Sweden, Seminariegatan 31, Uppsala | Sweden | Active | 12 May 2015 | View details → | |
|
Restylane® REFYNE™
|
Medical Devices for Humans | 20mg/1ml | Injection | Q-Med AB, Sweden, Seminariegatan 31, Uppsala | Sweden | Active | 30 Dec 2014 | View details → | |
|
Restylane® SKINBOOSTERS™ VITAL LIDOCAINE
|
Medical Devices for Humans | 20mg/ml | Injection | Q-Med AB, Sweden, Seminariegatan 31, Uppsala | Sweden | Active | 12 May 2015 | View details → | |
|
Restylane® SKINBOOSTERS™ VITAL LIGHT LIDOCAINE
|
Medical Devices for Humans | 12mg/ml | Injection | Q-Med AB, Sweden, Seminariegatan 21, Uppsala | Sweden | Active | 12 May 2015 | View details → | |
|
Restylane® VOLYME™
|
Medical Devices for Humans | 20mg/ml | Injection | Q-Med AB, Sweden, Seminariegatan 31, Uppsala | Sweden | Active | 30 Dec 2014 | View details → | |
|
Retevmo™ 120mg
|
Conventional Medicines | 120 mg/Tablets | Tablet | ELI LILLY AND COMPANY , United States of America, Indianapolis | United States of America | Active | 30 Sep 2025 | View details → | |
|
Retevmo™ 160mg
|
Conventional Medicines | 160 mg/Tablets | Tablet | ELI LILLY AND COMPANY , United States of America, Indianapolis | United States of America | Active | 30 Sep 2025 | View details → | |
|
Retevmo™ 40 mg
|
Conventional Medicines | 40 mg / capsule | Capsule | ELI LILLY AND COMPANY, United States of America, INDIANAPOLIS | United States of America | Active | 22 Oct 2020 | View details → | |
|
Retevmo™ 40mg
|
Conventional Medicines | 40 mg/Tablets | Tablet | ELI LILLY AND COMPANY , United States of America, Indianapolis | United States of America | Active | 30 Sep 2025 | View details → | |
|
Retevmo™ 80 mg
|
Conventional Medicines | 80 mg / capsule | Capsule | ELI LILLY AND COMPANY , United States of America, Indianapolis | United States of America | Active | 22 Oct 2020 | View details → | |
|
Retevmo™ 80 mg
|
Conventional Medicines | 80 mg / capsule | Capsule | ELI LILLY AND COMPANY , United States of America, Indianapolis | United States of America | Active | 22 Oct 2020 | View details → | |
|
Retevmo™ 80mg
|
Conventional Medicines | 80 mg/Tablets | Tablet | ELI LILLY AND COMPANY , United States of America, Indianapolis | United States of America | Active | 30 Sep 2025 | View details → | |
|
Retinac Gel 0.1%
|
Conventional Medicines | 0.1 % w/w | Gel | Vieco Pharmaceuticals FZCO, United Arab Emirates, Dubai | United Arab Emirates | Active | 15 Aug 2025 | View details → | |
|
RETROVIR
|
Conventional Medicines | 10mg/ml | Solution | BORA PHARMACEUTICAL SERVICES INC, Canada, Mississauga | United Kingdom | Active | 20 Mar 1993 | View details → | |
|
RETROVIR
|
Conventional Medicines | 10mg/ml | Solution | BORA PHARMACEUTICAL SERVICES INC, Canada, Mississauga | United Kingdom | Active | 20 Mar 1993 | View details → | |
|
REVANESSE® CONTOUR™ + With Lidocaine
|
Medical Devices for Humans | Device | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
REVANESSE® KISS™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
REVANESSE® OUTLINE™ +
|
Medical Devices for Humans | combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2022 | View details → | |
|
REVANESSE® PURE™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
REVANESSE® REVISE™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
REVANESSE® SHAPE™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
Revanesse® Ultra
|
Medical Devices for Humans | 25 mg/ml | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 29 Sep 2011 | View details → | |
|
REVANESSE® ULTRA™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → |
Compare selected products
0 of 3 selected